What is TuHURA Biosciences Inc (HURA) stock price today?

TuHURA Biosciences Inc (HURA) currently trades at $2.10 per share. The stock has a market capitalization of $141.14M and a P/E ratio of —x.

Is HURA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, TuHURA Biosciences Inc has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -8.20.

Is TuHURA Biosciences Inc financially healthy?

TuHURA Biosciences Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -8.20 places it in the distress.

HURA

TuHURA Biosciences Inc

NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY

$2.10

-1.41% today

Updated 2026-04-29

Market cap

$141.14M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.63

Dividend yield

—

52W range

$0 – $4

Volume

1.1M

Market cap

$141.14M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.63

Dividend yield

—

52W range

$0 – $4

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-8.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$8.40

+300.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.03x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -8.20 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.61M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-22.66M	$-14.65M	$-8.32M	$-21.68M	$-6.77M
EPS	—	—	—	—	$-0.63
Free cash flow	$-6.57M	$-7.74M	$-7.26M	$-14.79M	$-5.61M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HURA	$141.14M	16	4.3	3.0	5.0	4.5	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

TuHURA Biosciences Inc trades at $2.10. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -8.20, it sits in the distress.

Frequently asked questions

What is TuHURA Biosciences Inc's stock price?

TuHURA Biosciences Inc (HURA) trades at $2.10.

Is TuHURA Biosciences Inc overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of TuHURA Biosciences Inc (HURA)?

The analyst target price is $8.40, representing +300.0% upside from the current price of $2.10.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-8.20 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.tuhurabio.com

Quick metrics

P/S ratio—

ROE-169.20%

Beta—

50D MA$1.91

200D MA$1.95

Shares out0.06B

Float0.04B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HURA vs LLY →HURA vs JNJ →HURA vs ABBV →Stock screener →